Mitchell K. Fogelman
No más puestos en curso
Cargos activos de Mitchell K. Fogelman
Empresas | Cargo | Inicio | Fin |
---|
Historial de carrera de Mitchell K. Fogelman
Antiguos cargos conocidos de Mitchell K. Fogelman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Director Financiero/CFO | 29/01/2010 | 30/03/2011 |
LADRX CORPORATION | Director Financiero/CFO | 01/09/2007 | 31/12/2008 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - | - |
International Architectural Group LLC
International Architectural Group LLC AluminumNon-Energy Minerals International Architectural Group LLC manufactures building products. It specializes in aluminum and vinyl products. The company was founded in 1957 and is headquartered in Monterey Park, CA. | Director Administrativo | - | - |
Director Financiero/CFO | - | - | |
Secretario Corporativo | - | - |
Formación de Mitchell K. Fogelman.
University of California, Los Angeles | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Reino Unido | 2 |
Operativa
Director of Finance/CFO | 3 |
Chief Administrative Officer | 1 |
Corporate Secretary | 1 |
Sectorial
Health Technology | 3 |
Non-Energy Minerals | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LADRX CORPORATION | Health Technology |
Empresas privadas | 3 |
---|---|
International Architectural Group LLC
International Architectural Group LLC AluminumNon-Energy Minerals International Architectural Group LLC manufactures building products. It specializes in aluminum and vinyl products. The company was founded in 1957 and is headquartered in Monterey Park, CA. | Non-Energy Minerals |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Mitchell K. Fogelman
- Experiencia